Oncology in Sweden publishes an article by Magnus Essand on Elicera's iTANK platform and upcoming clinical study
August 31, 2022
Elicera's co-founder and CSo, professor Magnus Essand, publishes an article on the iTANK platform and the upcoming clinical study in Oncology in Sweden (in Swedish only).
By continuing to browse this website you agree to cookies being stored on your device in order to improve the experience and analyze how it is being used. Read more in our Integrity policy.